Glucagon-like peptide 1 receptor agonists (GLP-1RA), such as Ozempic and Wegovy, have been rapidly adopted for the treatment of obesity in both youth and adult…

Obesity/Therapy

~Estimated

~$10 – $6,250

University of Colorado, DenverNCT07021937

Observational

Comparison of Behaviorally-Based Remote Approaches to Optimize Weight Loss and Identification of Factors Which Characterize Treatment Response

The purpose of this trial is to compare two delivery formats for weight loss (automated online program vs. group-based videoconference program) and to examine …

Obesity/therapy

~Estimated

~$10 – $6,250

The Miriam HospitalNCT06875622

Phase 4

The Effects of Tirzepatide in Young Adults With Prader-Willi Syndrome, Hypothalamic Obesity and General Non-Syndromic Obesity

This research study is comparing the effectiveness of a weight loss medication called Tirzepatide in young adults with Prader-Willi Syndrome and/or hypothalami…

Prader-Willi SyndromeHypothalamic ObesityObesity/Therapy

~Estimated

~$10 – $7,500

Grace KimNCT06901245